10.3 Black Widow, Brown Recluse Spiders, and Bark Scorpion Stings

Arthropod envenomations represent thousands of annual consultations to poison control centers across the United States. While the vast majority of indigenous spider bites are clinically benign, two spider genera—Latrodectus (widow spiders) and Loxosceles (recluse spiders)—and one scorpion genus—Centruroides (bark scorpions)—produce severe, life-threatening clinical toxidromes. Each organism possesses a unique, highly specialized venom apparatus and pathophysiology: black widows induce explosive neurochemical exocytosis, brown recluses cause dermonecrosis and intravascular hemolysis via enzymatic membrane cleavage, and bark scorpions trigger uncoordinated repetitive axonal firing.

---

Black Widow Spiders (Latrodectus): alpha-Latrotoxin and Latrodectism

Widow spiders belong to the family Theridiidae, with three prominent North American species: the Southern black widow (Latrodectus mactans), Western black widow (Latrodectus hesperus), and Northern black widow (Latrodectus variolus). The female is readily recognized by her shiny, globose, jet-black abdomen (9 to 13 mm in body length) bearing a characteristic ventral bright red or orange hourglass marking.

Mechanism of Action: alpha-Latrotoxin

• Receptor Binding and Pore Formation: The principal bioactive venom constituent is alpha-latrotoxin, a potent high-molecular-weight protein. alpha-Latrotoxin binds with nanomolar affinity to specific presynaptic neuronal receptors: neurexins (calcium-dependent) and latrophilins / CIRL (calcium-independent).
• Massive Calcium Influx: Upon receptor binding, alpha-latrotoxin molecules assemble into tetrameric complexes that insert directly into the presynaptic terminal membrane, creating stable, non-gated cation-permeable pores.
• Catastrophic Neurotransmitter Surge: Unregulated extracellular calcium floods the nerve terminal, triggering the explosive, non-stop exocytosis of synaptic vesicles containing acetylcholine (ACh) and norepinephrine (NE) across somatic neuromuscular junctions, autonomic ganglia, and central synapses. Once vesicular stores are exhausted, a functional conduction block ensues.

Clinical Manifestations of Latrodectism

Bite (Mild Pinch) ──> Targetoid Local Lesion ──> Centripetal Spasms (30–120 min) ──> Board-Like Abdomen
                                            ──> Autonomic Storm (Hypertension, Tachycardia, Diaphoresis)

1. The Bite Site: The bite is often perceived as a sharp pinprick or mild pinch, occasionally going unnoticed. Within 30 to 60 minutes, a localized targetoid lesion appears: a central punctum or small vesicle surrounded by a blanched halo of arterial vasoconstriction, encircled by an outer rim of erythema.
2. Centripetal Muscle Spasms: Severe, agonizing muscle cramping begins near the bite and spreads centripetally into the large muscle groups of the thighs, lower back, chest, and abdomen. Spasms are intensely painful and wax and wane in intensity.
3. The 'Board-Like' Abdomen (Crucial Clinical Differentiator):
   • Envenomation of the lower extremity or trunk characteristically triggers severe, board-like abdominal wall rigidity.
   • The Triage Pearl: This presentation is frequently misdiagnosed as an acute surgical abdomen (e.g., ruptured appendicitis, perforated ulcer, or peritonitis). However, in latrodectism, the abdomen is completely non-tender to deep palpation between spasms, and true peritoneal signs (rebound tenderness, involuntary guarding, percussion tenderness) are absent. Identifying this distinction prevents unnecessary emergency laparotomies.
4. Facies Latrodectismica and Autonomic Chaos: Autonomic norepinephrine discharge produces severe hypertension, sinus tachycardia, diaphoresis, piloerection, urinary retention, and priapism in young boys. Facial envenomation or severe systemic toxicity manifests as facies latrodectismica—spastic grimacing, blepharospasm, marked periorbital edema, facial flushing, and diaphoresis.

Pharmacotherapy and Antivenom

• First-Line Symptomatic Therapy: Aggressive parenteral analgesia with intravenous opioids (morphine 0.1 mg/kg or fentanyl 1 to 2 mcg/kg) combined with intravenous benzodiazepines (lorazepam 1 to 2 mg or diazepam 5 to 10 mg) to alleviate skeletal muscle spasms and blunted autonomic storm.
• Obsolete Practice: Calcium Gluconate: Historically, intravenous calcium gluconate was widely advocated based on flawed theoretical assumptions regarding neuromuscular stabilization. Retrospective clinical data showed that calcium gluconate gives little or no pain relief compared with opioids and benzodiazepines, so it is no longer recommended.
• Equine Latrodectus Antivenin: A whole equine IgG antivenin is available. It provides dramatic pain relief within 30 to 60 minutes. However, because of high rates of acute equine hypersensitivity, anaphylaxis, and delayed serum sickness, antivenin is reserved strictly for:
  1. Severe, intractable pain refractory to high-dose parenteral opioids and benzodiazepines.
  2. Life-threatening hypertensive crises or myocardial ischemia.
  3. Envenomation during pregnancy (severe latrodectism induces strong uterine contractions, risking preterm labor and spontaneous abortion).
  4. Patients at extremes of age with severe cardiopulmonary compromise.

---

Brown Recluse Spiders (Loxosceles): Sphingomyelinase D and Loxoscelism

Recluse spiders belong to the family Sicariidae, with the brown recluse (Loxosceles reclusa) indigenous to the south-central and midwestern United States (centered around Arkansas, Missouri, Oklahoma, Tennessee, and Kentucky). They are shy, non-aggressive spiders found in dark, dry, undisturbed spaces (closets, attics, woodpiles, behind baseboards).

Morphology: The Violin Pattern and Eye Arrangement

• Dorsal Cephalothorax: Uniformly tan to dark-brown body with a characteristic dark violin- or fiddle-shaped marking on the dorsal cephalothorax (with the neck of the violin pointing backward toward the abdomen).
• The Eye Pattern (Definitive Feature): While the vast majority of spiders possess 8 eyes in two rows of 4, Loxosceles spiders possess only 6 eyes arranged in 3 distinct dyads (pairs) forming a semicircle across the front of the cephalothorax.

Normal Spider Eyes:   ( o o o o )   ( 8 Eyes in 2 Rows )
                      ( o o o o )
Loxosceles Eye Dyads:    (oo)       ( 6 Eyes in 3 Dyads Forming a Semicircle )
                       (oo)  (oo)

Pathophysiology: Sphingomyelinase D

Unlike most venomous enzymes that rely on hyaluronidase or metalloproteinases, the primary toxic driver of Loxosceles venom is sphingomyelinase D (SMase D).

1. Membrane Hydrolysis: Sphingomyelinase D selectively cleaves sphingomyelin on cell membranes, releasing choline and generating ceramide-1-phosphate.
2. Complement Activation and Chemotaxis: Ceramide-1-phosphate and cleaved membrane fragments activate the alternative complement cascade (C3a, C5a), provoking massive neutrophil adhesion, chemotaxis, and degranulation.
3. Microvascular Thrombosis: Infiltrating polymorphonuclear leukocytes release elastase and myeloperoxidase, causing vascular endothelial swelling, platelet aggregation, and fibrin occlusion of dermal microvessels. The resulting localized tissue ischemia precipitates dermonecrosis.

Clinical Manifestations of Loxoscelism

1. Cutaneous Loxoscelism

• Initial Bite: Bites are characteristically painless or feel like a mild stinging sensation. Most bites heal uneventfully without necrosis.
• 24 to 48 Hours: The 'Red, White, and Blue' Sign:
  • Blue: A central, sinking violaceous or bluish-gray ischemic bleb or sink.
  • White: A pale, blanched halo of intense arterial vasospasm surrounding the central zone.
  • Red: An outer, irregular, non-concentric erythematous flare.
• Days 5 to 14: Eschar and Ulceration: The central blue zone becomes dark, dry, and necrotic, forming a sunken, leathery black eschar. Over 2 to 4 weeks, the eschar sloughs, leaving an indolent, deep dermonecrotic ulcer with jagged margins that can take 6 to 12 weeks to heal by secondary intention.

2. Viscerocutaneous (Systemic) Loxoscelism

Occurs in a small subset of patients, disproportionately affecting young children and adolescents within 24 to 72 hours of the bite:

• Massive Intravascular Hemolysis: Sphingomyelinase D cleaves red blood cell membrane sphingomyelin, triggering complement-mediated Coombs-negative intravascular hemolysis, spherocytosis, and severe anemia.
• Acute Kidney Injury (AKI): Massive hemoglobinuria overwhelms renal tubular haptoglobin binding, precipitating intratubular cast formation and direct heme pigment nephropathy (acute tubular necrosis).
• Disseminated Intravascular Coagulation (DIC): Severe thrombocytopenia, bleeding, and multi-organ failure, carrying a significant risk of pediatric mortality.

Clinical Management: The Strict Rule Against Early Excision

• Local Wound Care: Conservative management with Rest, Ice, Compression, and Elevation (R.I.C.E.). Cold compresses slow the enzymatic velocity of sphingomyelinase D. Ensure tetanus vaccination is updated.
• STRICT SURGICAL CONTRAINDICATION: NO EARLY EXCISION:
  • Surgical excision or aggressive debridement of an active Loxosceles lesion during the first 2 to 3 weeks is strictly contraindicated. Excising active tissue accelerates venom spread, creates massive, non-healing tissue defects, damages underlying tendons and nerves, and worsens scarring. Surgical debridement or skin grafting is considered strictly after the lesion has fully demarcated and stabilized, typically 4 to 8 weeks post-bite.
• Dapsone Warning: Dapsone was historically prescribed to inhibit neutrophil myeloperoxidase. However, clinical studies show no clear benefit, and dapsone carries life-threatening risks: severe methemoglobinemia and hemolytic anemia, especially in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Dapsone is not recommended.
• Systemic Loxoscelism Protocol: In children with fever, dark urine, or pallor, obtain immediate CBC, urinalysis (checking for hemoglobinuria without RBCs), reticulocyte count, haptoglobin, total bilirubin, and renal function. Treat systemic loxoscelism with aggressive intravenous hydration (target urine output 1.5 to 2 mL/kg/hour), urinary alkalinization, and packed red blood cell transfusions for severe hemolysis.

---

Bark Scorpions (Centruroides sculpturatus): Sodium Channel Neurotoxicity

The Arizona bark scorpion (Centruroides sculpturatus, previously Centruroides exilicauda) is the only scorpion species in the United States capable of producing life-threatening envenomation. Indigenous to the Sonoran Desert (Arizona, southern Nevada, southwestern Utah, and western New Mexico), bark scorpions are 2 to 7 cm long, light brown or yellowish-tan, and possess slender pedipalps (pincers) and a small subaculear tooth beneath the venomous stinger on the telson.

Mechanism of Action: Sodium Channel Hyperexcitability

Bark scorpion venom contains low-molecular-weight basic polypeptides (alpha- and beta-scorpion toxins) that bind with high affinity to voltage-gated sodium channels (Nav) and potassium channels (Kv) on axonal membranes:

• Centruroides beta-toxins bind receptor site 4 and shift channel activation to more negative potentials, while alpha-type toxins slow inactivation; together they make sodium channels open more easily and stay open longer.
• This produces massive, uncoordinated, repetitive electrical firing of sensory, motor, and autonomic axons throughout the peripheral nervous system.

Clinical Staging and Manifestations

Grade I: Local Pain / Paresthesias ──> Grade II: Remote Paresthesias ──> Grade III: Cranial Nerve OR Motor Signs
                                                                    ──> Grade IV: BOTH Cranial Nerve AND Motor Signs

1. Local Hyperesthesia and the Pathognomonic 'Tap Test':
   • Envenomation causes instantaneous, excruciating, burning local pain and paresthesias.
   • The Tap Test: Lightly tapping or percussing the sting site produces an immediate, disproportionate jolt of excruciating pain, paresthesias, and involuntary withdrawal. Crucially, the sting site displays virtually no visible swelling, erythema, or local inflammation!
2. Systemic Neurotoxicity (The Pediatric Emergency):
   • While adults typically experience only local pain and paresthesias (Grade I or II), infants and children under 5 years old rapidly develop severe systemic neurotoxicity (Grade III or IV).
   • Cranial Nerve Dysfunction: Chaotic, dysconjugate, involuntary saccadic roving eye movements (opsoclonus), nystagmus, tongue fasciculations, pharyngeal dyscoordination, and loss of airway protective reflexes.
   • Autonomic Storm: Profuse drooling (hypersalivation), copious bronchorrhea, diaphoresis, tachycardia, and hypertension.
   • Somatic Motor Agitation: Severe restlessness, flailing, jerking, and involuntary choreoathetoid movements of the extremities (somatic motor thrashing). Critical Clinical Distinction: Patients remain awake and fully alert during motor thrashing. It is NOT an epileptic seizure; standard anticonvulsants (such as phenytoin) are completely ineffective.

Treatment and Anascorp Antivenom

• Airway Support: Continuous suctioning of excessive oral secretions is mandatory to prevent pulmonary aspiration.
• Benzodiazepine Sedation: In mild-to-moderate envenomations, high-dose intravenous benzodiazepines (midazolam 0.1 to 0.2 mg/kg or lorazepam 0.1 mg/kg) can blunt neuromuscular thrashing and autonomic agitation.
• Anascorp (Centruroides [Scorpion] Immune F(ab')2 [Equine]):
  • Indications: Indicated for Grade III and Grade IV envenomations (especially in pediatric patients with cranial nerve deficits, roving eye movements, or severe motor thrashing).
  • Dosing: Administer 3 vials IV reconstituted and diluted in 50 mL normal saline, infused over 30 minutes.
  • Clinical Response: Anascorp dramatically neutralizes circulating venom toxins, resolving cranial nerve dysfunction and motor thrashing within 1 to 4 hours (mean time to resolution ~90 minutes, compared to 12 to 24+ hours with benzodiazepine sedation alone), drastically eliminating the need for endotracheal intubation and pediatric ICU admission. If symptoms persist, additional doses of 1 vial at a time may be given at 30- to 60-minute intervals (per the product label).